Changes

Jump to navigation Jump to search
no edit summary
Line 9: Line 9:  
==Description==
 
==Description==
   −
Equins Serum Hepatitis (ESH) leading to acute liver failure is most commonly associated with administration of an equine biologic product. This is usually tetanus antitoxin, but others such as encephalitis vaccines and equine serum have been implicated. Other causes including alkaloid toxicity and mycotoxins have been hypothesised.  
+
Equins Serum Hepatitis (ESH) leading to acute liver failure is most commonly associated with administration of an equine biologic product. This is usually tetanus antitoxin, but encephalitis vaccines and equine serum have also been implicated. Other possible hypotheses include alkaloid toxicity and mycotoxins.
      Line 20: Line 20:  
==Clinical Signs==
 
==Clinical Signs==
   −
The history may include administration of an equine-derived biologic product. Clinical signs may range from mild lethargy or inappetance to signs of acute or chronic hepatic failure. They are generally sudden in onset and rapidly progressive. The course of the disease is usually around five days, with either death or recovery occuring within ten days.  
+
The history may include administration of an equine-derived biologic product, often four to six weeks prior to the onset of clinical signs. These may range from mild lethargy or inappetance to signs of acute or chronic hepatic failure. They are generally sudden in onset and rapidly progressive. The course of the disease is usually around five days, with either death or recovery occuring within ten days.  
    
Signs may include the following:
 
Signs may include the following:
Line 39: Line 39:  
==Pathology==
 
==Pathology==
   −
 
+
Post mortem examination often shows the liver to be enlarged and pale with rounded edges. Generalised icterus is often present. Histologically there may be centrilobular necrosis with mononuclear cell accumulation within the portal triads.
     
906

edits

Navigation menu